logo

Last Update

This profile was last updated on 6/15/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Doug Broeska?

Doug Broeska

President

The CliniCard Inc

Email: d***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The CliniCard Inc

1213 Chevrier Blvd

Winnipeg, Manitoba,R3T 1Y4

Canada

Company Description

The CliniCard is able to securely deliver automatically adjudicated health benefits at any Provider with one simple and seamlessly integrated payment card. The patented method means that multiple forms of payment transactions by specific Providers can be perfo...more

Background Information

Employment History

PhD Medical Researcher and Chief Executive Officer

Regenetek Research Inc


Contributor

Software Magazine


Affiliations

International Cellular Medicine Society

Member


Education

BSc

University of Manitoba


PhD

Brightland University


PhD

University of Manitoba


degree

philosophy

Brightland University


Web References(51 Total References)


The CliniCard

www.theclinicard.com [cached]

Doug Broeska, President of The CliniCard, Inc., said in a statement that "it's no secret that the medical adjudication and payments industry is seriously flawed and inefficient.


Merchant360, Health Portal Solutions, and CliniCard Ally to Improve Patient ID & Payments with NFC |

merchant360.net [cached]

Doug Broeska, president of The CliniCard Inc, said in a statement that "Mobile commerce through NFC is already here through the growing availability of NFC-ready personal handsets looking for plug in uses.


Merchant360, Health Portal Solutions, and CliniCard Ally to Improve Patient ID & Payments with NFC |

merchant360.net [cached]

Doug Broeska, president of The CliniCard Inc, said in a statement that "Mobile commerce through NFC is already here through the growing availability of NFC-ready personal handsets looking for plug in uses.


www.winnipegfreepress.com

Doug Broeska, known to patients as "Dr.
Doug," claimed the treatment was "curative" and that every patient saw significant benefit from the treatment. Many did, but, a Free Press investigation found at least a half-dozen patients saw no effects from their treatments in India and received no follow-up, which is common in a clinical trial. They are angry and believe they have been duped. Until recently, Broeska was the principal investigator on the clinical trial. He claimed to have a BSc and a PhD, first from the University of Manitoba. Then he claimed to have a PhD from "Brightland University." He does not hold any degree from the U of M, and Brightland University does not exist. Broeska also claimed to be a member of the International Cellular Medicine Society and to have approval for his clinical trial from "several" ethical panels. The College of Physicians and Surgeons of Manitoba, which first became aware of Broeska and his MS therapies in 2011, has so far been hands-off. In emails to the Free Press, other media and to patients, Broeska has repeatedly said he received a PhD, never offered medical advice to patients and that the clinical trial is a legitimate, duly registered study that is based in India. While many Regenetek patients saw their MS symptoms shrink, many others did not, and began raising questions about Broeska and his treatment. Broeska was in Trinidad last week, meeting with medical researchers from India to open another clinic. Hauch was in Trinidad last week with Broeska but said she has no involvement in plans to expand the stem cell clinic to the Caribbean country. She said she travelled to Trinidad to meet with representatives from Inamdar Hospital in Pune to discuss plans for a companion study on physiotherapies for stem cell patients. That study was to be done in conjunction with the University of Winnipeg, but the school cut ties with Regenetek last week following a Free Press investigation. Manitoba company records list Hauch as a director, along with Broeska, of CliniCard Inc, a company related to Regenetek and located in the same office on Chevrier Boulevard. In emails to the Free Press, the CBC and patients in recent days, Broeska has vigorously denied the allegations about him and Regenetek. He said he stands behind his company's role in the clinical study, which he said was only to track patients upon their return from India. "We are scientists simply tracking the progress of participants who have chosen to attempt innovative therapy options and to have their results noted by us for scientific study," said Broeska in a statement.


www.winnipegfreepress.com

While many Regenetek patients saw their MS symptoms shrink, many others did not, and began raising questions about Broeska and his treatment.
Broeska was in Trinidad last week, meeting with medical researchers from India to open another clinic. Hauch was in Trinidad last week with Broeska but said she has no involvement in plans to expand the stem cell clinic to the Caribbean country. She said she travelled to Trinidad to meet with representatives from Inamdar Hospital in Pune to discuss plans for a companion study on physiotherapies for stem cell patients. nd Manitoba company records list Hauch as a director, along with Broeska, of CliniCard Inc, a company related to Regenetek and located in the same office on Chevrier Boulevard. In emails to the Free Press, the CBC and patients in recent days, Broeska has vigorously denied the allegations about him and Regenetek. He said he stands behind his company's role in the clinical study, which he said was only to track patients upon their return from India. "We are scientists simply tracking the progress of participants who have chosen to attempt innovative therapy options and to have their results noted by us for scientific study," said Broeska in a statement. Doug Broeska, known to patients as "Dr. Doug," claimed the treatment was "curative" and that every patient saw significant benefit from the treatment. Many did, but, a Free Press investigation found at least a half-dozen patients saw no effects from their treatments in India and received no follow-up, which is uncommon in a clinical trial. They are angry and believe they have been duped. Until recently, Broeska was the principal investigator on the clinical trial. He claimed to have a BSc and a PhD, first from the University of Manitoba. Then he claimed to have a PhD from "Brightland University." He does not hold any degree from the U of M, and Brightland University does not exist. Brightland University has a barebones website that appears phony, misspells "Brightland" and includes no contact information, such as an address, for the school. An investigation into the website's architecture showed links to University Degrees Program, which was a well-known degree mill operating dozens of fraudulent institutions. Broeska also claimed to be a member of the International Cellular Medicine Society and to have approval for his clinical trial from "several" ethical panels. The College of Physicians and Surgeons of Manitoba, which first became aware of Broeska and his MS therapies in 2011, has so far been hands-off. In emails to the Free Press, other media and to patients, Broeska has repeatedly said he received a PhD, never offered medical advice to patients and that the clinical trial is a legitimate, duly registered study that is based in India.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory